Results 291 to 300 of about 365,351 (311)

β-blockers, angiotensin II, and ACE inhibitors in patients with heart failure

Lancet, The, 2001
Duncan J Campbell, Murray Esler, David M Kaye   +2 more
exaly  

New Angiotensin-II Blocker

American Journal of Nursing, 1996
L L, Lilley, R, Guanci
openaire   +2 more sources

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial

Lancet, The, 2011
Else Charlotte Sandset, Dalius Jatuzis, Janika Kõrv   +2 more
exaly  

Angiotensin II

2015
openaire   +1 more source

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

Lancet, The, 2005
Liam Smeeth, Aroon D Hingorani
exaly  

[Angiotensin I, angiotensin II, angiotensin III].

Nihon rinsho. Japanese journal of clinical medicine, 2005
openaire   +1 more source

[Angiotensin II].

Nihon rinsho. Japanese journal of clinical medicine, 1996
Y, Wanaka, N, Nakamura, Y, Ueno
openaire   +1 more source

Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure

Lancet, The, 2017
Milton Packer, John J V Mcmurray
exaly  

Sepsis and angiotensin II

Journal of Cardiothoracic and Vascular Anesthesia, 1991
openaire   +2 more sources

Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction

Lancet, The, 1994
exaly